精神分裂症相关MAD1调控发育中新皮层迁移神经元的极性
本研究探讨MAD1L1基因产物MAD1在神经发育中的作用,利用小鼠和人脑类器官发现MAD1在皮层发育活跃期高表达,其缺失导致神经元迁移和神经突生长受损。MAD1定位于高尔基体,调控囊泡运输,并与KIFC3协作调节高尔基体形态和神经元极性,从而确保神经元正确迁移和分化,提示MAD1异常可能参与精神分裂症病理。
要点
- MAD1缺失导致小鼠和人类脑类器官神经元迁移及神经突生长受损。
- MAD1定位于高尔基体,调控囊泡从高尔基体向质膜的运输。
- MAD1与KIFC3协作调节高尔基体形态和神经元极性。
核心结论
- MAD1是神经元发育的关键调控因子,其改变可能构成精神分裂症病理基础。
研究设计与样本
- 研究采用小鼠和人类脑类器官,检测MAD1在皮层发育中的表达及其缺失对神经元迁移和神经突生长的影响。
主要发现
- MAD1在皮层发育活跃期高表达,其缺失导致神经元迁移和神经突生长受损。
- MAD1定位于高尔基体,调控囊泡从高尔基体向质膜的运输,该过程为迁移神经元生长和极性所必需。
- MAD1与KIFC3物理相互作用并协作,调节高尔基体形态和神经元极性,确保神经元正确迁移和分化。
临床怎么用
- 本研究为机制探索,尚不能直接指导临床实践,但提示MAD1/KIFC3通路可能作为精神分裂症病理研究的潜在方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although large-scale genome-wide association studies (GWAS) have identified an association between MAD1L1 (Mitotic Arrest Deficient-1 Like 1) and the pathology of schizophrenia, the molecular mechanisms underlying this association remain unclear. In the present study, we aimed to address these mechanisms by examining the role of MAD1 (the gene product of MAD1L1) in key neurodevelopmental processes in mice and human organoids. Our findings indicated that MAD1 is highly expressed during active cortical development and that MAD1 deficiency leads to impairments in neuronal migration and neurite outgrowth. We also observed that MAD1 is localized to the Golgi apparatus and regulates vesicular trafficking from the Golgi apparatus to the plasma membrane, which is required for the growth and polarity of migrating neurons. In this process, MAD1 physically interacts and collaborates with the kinesin-like protein KIFC3 (kinesin family member C3) to regulate the morphology of the Golgi apparatus and neuronal polarity, thereby ensuring proper neuronal migration and differentiation. Consequently, our findings indicate that MAD1 is an essential regulator of neuronal development and that alterations in MAD1 may underlie schizophrenia pathobiology.
引用
- Goo BS, Mun DJ, Kim S, et al. Schizophrenia-associated Mitotic Arrest Deficient-1 (MAD1) regulates the polarity of migrating neurons in the developing neocortex. Mol Psychiatry. 2022. PMID: 36357673. doi:10.1038/s41380-022-01856-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。